# US 2026/0077023 A1 · Antimicrobial hydrolyzed collagen with polylysine and methods of using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0077023 A1
- Document ID: US20260077023A1
- Status: Published application
- Kind: A1
- Application number: 19/328,859
- Filed: 2025-09-15
- Published: 2026-03-19
- Earliest claimed: 2024-09-14
- Assignees: Rochal Technologies, LLC
- Applicants: Rochal Technologies, LLC
- Inventors: Bradley RODIER; Larry ESTLACK; Rebecca McMAHON; Nina BIONDA; Ann BEAL SALAMONE; Tiffany Fawn SANCHEZ; Sergio MEDINA; Jonathan VELASCO; Fahimeh TABATABAEI
- Web page: https://patentgrep.com/patent/US20260077023A1

## CPC

- A01N 61/00: Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
- A61K 38/39: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A61K 8/00: Cosmetics or similar toiletry preparations
- A61K 8/65: Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A61K 47/183: {Amino acids, e.g. glycine, EDTA or aspartame}
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- A61L 26/00: Chemical aspects of, or use of materials for, {wound dressings or} bandages {in liquid, gel or powder form}
- A61L 33/00: Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61P 31/04: Antibacterial agents
- A61Q 19/00: Preparations for care of the skin
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A hydrolyzed collagen-based composition comprising hydrolyzed collagen and 0.01 to 50 wt-% of polylysine based on the percent solids of the hydrolyzed collagen-based composition is provided. Methods of treating tissue (e.g., impaired tissue) are also provided.

## Claims

### Claim 1

A hydrolyzed collagen-based composition comprising hydrolyzed collagen and 0.01 to 50 wt-% of polylysine based on the percent solids of the hydrolyzed collagen-based composition.

### Claim 2 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, comprising 0.05 to 25 wt-% of polylysine based on the percent solids of the hydrolyzed collagen-based composition.

### Claim 3 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, comprising 0.1 to 2 wt-% of polylysine based on the percent solids of the hydrolyzed collagen-based composition.

### Claim 4 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, wherein the polylysine comprises ε-polylysine.

### Claim 5 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, wherein the polylysine comprises α-polylysine.

### Claim 6 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, wherein the polylysine comprises both ε-polylysine and α-polylysine.

### Claim 7 (depends on 6)

The hydrolyzed collagen-based composition of claim 6, wherein a weight ratio of ε-polylysine to α-polylysine ranges from 1:5 to 5:1.

### Claim 8 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, wherein the composition exhibits a kill rate of at least 1 log reduction of planktonic microbes.

### Claim 9 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, wherein the composition enhances a natural tissue regeneration process.

### Claim 10 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, further comprising 0.1 to 5 wt-% of a laurate ester based on the percent solids of the composition.

### Claim 11 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, comprising a chelating agent selected from the group consisting of aminocarboxylic acids, citric acid and its salts, ethylenediaminetetraacetic acid (EDTA), nitrilotriacetic acid, nitrilotripropionic acid, diethylenetriaminepentaacetic acid, 2-hydroxyethylethylenediaminetriacetic acid, 1,6-diaminohexamethylenetetraacetic acid, 1,2-diaminocyclohexanetetraacetic acid, O,O′-bis(2-aminoethyl)ethyleneglycoltetraacetic acid, 1,3-diaminopropanetetraacetic acid, N,N′-bis(2-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid, ethylenediamine-N,N′-diacetic acid, ethylenediamine-N,N′-dipropionic acid, triethylenetetraaminehexaacetic acid, ethylenediamine-N,N′-bis(methylenephosphonic acid), iminodiacetic acid, N,N′-bis(2-hydroxyethyl)glycine, 1,3-diamino-2-hydroxypropanetetraacetic acid, 1,2-diaminopropanetetraacetic acid, ethylenediaminetetrakis(methylenephosphonic acid), N-(2-hydroxyethyl)iminodiacetic acid and biphosphonates.

### Claim 12 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, further comprising a biologically active agent selected from cells, stem cells, amniotic tissue, amniotic cells, growth factors, micronized decellularized tissue, granulated crosslinked bovine tendon collagen and glycosaminoglycans, antiprotozoal agents, sporicidal agents, antiparasitic agents, peripheral neuropathy agents, neuropathic agents, chemotactic agents, analgesic agents, anti-inflammatory agents, anti-allergic agents, anti-hypertension agents, mitomycin-type antibiotics, polyene antifungal agents, antiperspirant agents, decongestants, anti-kinetosis agents, central nervous system agents, wound healing agents, anti-VEGF agents, anti-tumor agents, escharotic agents, anti-psoriasis agents, anti-diabetic agents, anti-arthritis agents, anti-itching agents, antipruritic agents, anesthetic agents, anti-malarial agents, dermatological agents, anti-arrhythmic agents, anti-convulsants, antiemetic agents, anti-rheumatoid agents, anti-androgenic agents, anthracyclines, anti-smoking agents, anti-acne agents, anticholinergic agents, anti-aging agents, antihistamines, anti-parasitic agents, hemostatic agents, vasoconstrictors, vasodilators, thrombogenic agents, anti-clotting agents, cardiovascular agents, angina agents, erectile dysfunction agents, sex hormones, growth hormones, isoflavones, integrin binding sequences, biologically active ligands, cell attachment mediators, immunomodulators, tumor necrosis factor alpha, anti-cancer agents, anti-depressant agents, antitussive agents, anti-neoplastic agents, narcotic antagonists, anti-hypercholesterolemia agents, apoptosis-inducing agents, birth control agents, sunless tanning agents, emollients, alpha-hydroxyl acids, manuka honey, topical retinoids, hormones, tumor-specific antibodies, antisense oligonucleotides, small interfering RNA (siRNA), anti-VEGF RNA aptamer, nucleic acids, DNA, DNA fragments, DNA plasmids, Si-RNA, transfection agents, vitamins, essential oils, liposomes, exosomes, silver nanoparticles, gold nanoparticles, drug-containing nanoparticles, albumin-based nanoparticles, chitosan-containing nanoparticles, polysaccharide-based nanoparticles, dendrimer nanoparticles, phospholipid nanoparticles, iron oxide nanoparticles, bismuth nanoparticles, gadolinium nanoparticles, metallic nanoparticles, ceramic nanoparticles, silica-based nanoparticles, virus-based nanoparticles, virus-like nanoparticles, nitric oxide-containing nanoparticles, nanoshells, nanorods, polymeric micelles, quantum dots nanoparticles, polymer-based microparticles, polymer-based microspheres, drug-containing microparticles, drug-containing microspheres, salicylic acid, benzoyl peroxide, 5-tluorouracil, nicotinic acid, nitroglycerin, clonidine, estradiol, testosterone, nicotine, motion sickness agents, scopolamine, fentanyl, diclofenac, buprenorphine, bupivacaine, ketoprofen, opioids, cannabinoids, enzymes, enzyme inhibitors, proteins, prodrugs, protease inhibitors, hyaluronic acid, chondroitin sulfate, dermatan sulfate, para-sympatholytic agents, hair growth agents, lipids, glycolipids, glycoproteins, endocrine hormones, growth hormones, growth factors, differentiation factors, heat shock proteins, immunological response modifiers, saccharides, polysaccharides, insulin and insulin derivatives, steroids, corticosteroids, and non-steroidal anti-inflammatory drugs or similar materials, in either their salt form or their neutral form, either being inherently hydrophilic or encapsulated within a hydrophilic microparticle or nanoparticle.

### Claim 13 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, further comprising at least one of cells, stem cells, amniotic tissue, amniotic cells, exosomes, growth factors, micronized decellularized tissue, granulated collagen, gelatin, or glycosaminoglycans.

### Claim 14 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, further comprising at least one additional ingredient selected from glycolipids, glycoproteins, immunological response modifiers, saccharides, and polysaccharides.

### Claim 15 (depends on 1)

The hydrolyzed collagen-based composition of claim 1, wherein the composition has a form selected from a powder, a liquid, a gel, a paste, a cream, a suspension, an emulsion, a film, a sheet, a foam, a lotion, a spray, an aerosol, a capsule, or a tablet.

### Claim 16 (depends on 1)

A method of treating tissue comprising contacting the tissue with a hydrolyzed collagen-based composition of claim 1.

### Claim 17 (depends on 16)

The method of claim 16, wherein the tissue being treated is impaired tissue.

### Claim 18 (depends on 16)

The method of claim 16, wherein the hydrolyzed collagen-based composition comprises a polylysine comprising ε-polylysine, α-polylysine, or a combination thereof.

### Claim 19 (depends on 16)

The method of claim 16, wherein the hydrolyzed collagen-based composition exhibits a kill rate of at least 1 log of planktonic microbes.

### Claim 20 (depends on 16)

The method of claim 16, wherein the hydrolyzed collagen-based composition enhances a natural tissue regeneration process.
